These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3565417)

  • 1. ASHP technical assistance bulletin on institutional use of controlled substances.
    Am J Hosp Pharm; 1987 Mar; 44(3):580-9. PubMed ID: 3565417
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP technical assistance bulletin on use of controlled substances in organized health care settings.
    Am J Hosp Pharm; 1993 Mar; 50(3):489-501. PubMed ID: 8442469
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP congressional testimony on the "gray market" in pharmaceuticals.
    Am J Hosp Pharm; 1986 Feb; 43(2):426-9. PubMed ID: 3953608
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP technical assistance bulletin on surgery and anesthesiology pharmaceutical services.
    Am J Hosp Pharm; 1991 Feb; 48(2):319-25. PubMed ID: 2003509
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 6. Should a registered pharmacist sign P.O. for a controlled drug?
    Decker R
    Hosp Purch Manage; 1981 Aug; 6(8):16. PubMed ID: 10252238
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of drug-related crimes reveals need for more security.
    Lee RJ
    Hosp Prog; 1975 Mar; 56(3):60-1, 74. PubMed ID: 1126712
    [No Abstract]   [Full Text] [Related]  

  • 9. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 10. Congress prepares laws to halt drug diversion.
    Wilkinson R
    Hospitals; 1986 Feb; 60(3):64. PubMed ID: 3943821
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory controversy surrounding ipecac use and misuse.
    Brushwood DB; Tietze KJ
    Am J Hosp Pharm; 1986 Jan; 43(1):157-61. PubMed ID: 2869686
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled substances registration for nonlicensed physicians.
    Alexander V; Lazarus H; McGovern H
    Hospitals; 1978 Oct; 52(19):165-6, 168, 170. PubMed ID: 689606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies.
    Am J Hosp Pharm; 1985 Jul; 42(7):1583-91. PubMed ID: 4025363
    [No Abstract]   [Full Text] [Related]  

  • 14. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
    Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting rehabilitation for the impaired healthcare employee: a case study.
    Genaro BA; Replogle JH
    Hosp Pharm; 1989 Aug; 24(8):601-3. PubMed ID: 10318302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEA authority to levy fine for noncompliance with controlled-substance records.
    Ensor PA
    Am J Hosp Pharm; 1992 Jan; 49(1):38, 44. PubMed ID: 1570864
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription mania.
    Shine L
    Tex Hosp; 1981 May; 36(12):57-9. PubMed ID: 10251652
    [No Abstract]   [Full Text] [Related]  

  • 20. Dealing with substance abuse in the workplace.
    Malatestinic WN; Jorgenson JA
    Hosp Pharm; 1991 Feb; 26(2):102-5. PubMed ID: 10170679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.